What triggered the board's decision to approve an additional $40 million authorization?

The filing does not explicitly state the board's rationale, but the timing coincides with strong Q2 2026 results (28% net sales growth, $49 million net income, and $279 million in cash with no debt), as well as raised full-year guidance and the Copra acquisition announced on July 22, 2026. These factors suggest the board approved the authorization based on demonstrated operational strength and cash generation.

How much of the original authorization has been used?

As of June 30, 2026, the company had repurchased approximately $44 million of common stock and had $21 million remaining under the existing authorization. During the six months ended June 30, 2026, and year-to-date through July 22, 2026, the company repurchased $20 million.

What is the execution mechanism for this repurchase program?

The filing does not specify the execution mechanism (e.g., Rule 10b-18 open-market purchases, 10b5-1 plan, accelerated share repurchase, or tender offer). The company's prior execution details are not disclosed in this earnings release.

How does the repurchase program compare to the company's market capitalization?

Based on approximately 57.4 million shares outstanding as of June 30, 2026, the total authorized amount of $105 million represents roughly 1.8% of market cap at current levels, a conservative approach typical of beverage companies balancing capital returns with investment in growth and acquisitions.

Will this repurchase program affect the company's financial flexibility?

No material effect is expected. Vita Coco maintains a strong balance sheet with $279 million in cash and zero debt as of June 30, 2026. The company also raised full-year 2026 guidance, indicating confidence in cash flow generation sufficient to fund operations, growth investments (including the Copra acquisition), and the buyback program.

What is the timing and duration of the repurchase authorization?

The filing does not specify an expiration date for the authorization or details on timing of share repurchases. Repurchases typically occur opportunistically under Rule 10b-18 safe harbor or through a 10b5-1 trading plan unless otherwise specified by the board.

COCO 8-K Filed 2026-07-23 New authorization

Vita Coco authorizes additional $40M share buyback program

Board approves new authorization on July 21, company raises full-year guidance amid strong Q2 results

Authorization$40M

MechanismNot specified

What the filing says

The Vita Coco Company (NASDAQ: COCO) announced on July 23, 2026, that its board of directors approved an additional $40 million share repurchase authorization on July 21, 2026. This new authorization increases the total authorized amount under the company's share repurchase program to $105 million.

As of June 30, 2026, Vita Coco had repurchased approximately $44 million of common stock under its existing share repurchase program, with $21 million remaining under the prior authorization. During the six months ended June 30, 2026, and year-to-date through July 22, 2026, the company repurchased $20 million of common stock. The execution mechanism is not specified in the filing.

The buyback authorization comes as Vita Coco reported strong second-quarter 2026 results, with net sales of $216 million (up 28% year-over-year) and raised its full-year 2026 guidance for net sales to between $790 million and $805 million, and Adjusted EBITDA to between $154 million and $161 million. The company also announced the acquisition of Copra, Inc. on July 22, 2026.

On July 21, 2026, the Board approved an additional $40 million authorization, increasing the total authorized amount under the program to $105 million. — Vita Coco Company, Inc. 8-K filing · View on SEC EDGAR →

What this means

The $40 million new authorization extends Vita Coco's repurchase capacity and reflects confidence in the company's financial position and market outlook. With $279 million in cash, no debt, and strong operational momentum (28% net sales growth in Q2), the company has substantial financial flexibility to execute the program. The cumulative authorized amount of $105 million represents approximately 1.8% of the company's current market capitalization (based on ~57.4 million shares outstanding), a measured approach typical of mid-cap beverage companies managing both return of capital and growth investments.

Frequently asked questions

What triggered the board's decision to approve an additional $40 million authorization?: The filing does not explicitly state the board's rationale, but the timing coincides with strong Q2 2026 results (28% net sales growth, $49 million net income, and $279 million in cash with no debt), as well as raised full-year guidance and the Copra acquisition announced on July 22, 2026. These factors suggest the board approved the authorization based on demonstrated operational strength and cash generation.
How much of the original authorization has been used?: As of June 30, 2026, the company had repurchased approximately $44 million of common stock and had $21 million remaining under the existing authorization. During the six months ended June 30, 2026, and year-to-date through July 22, 2026, the company repurchased $20 million.
What is the execution mechanism for this repurchase program?: The filing does not specify the execution mechanism (e.g., Rule 10b-18 open-market purchases, 10b5-1 plan, accelerated share repurchase, or tender offer). The company's prior execution details are not disclosed in this earnings release.
How does the repurchase program compare to the company's market capitalization?: Based on approximately 57.4 million shares outstanding as of June 30, 2026, the total authorized amount of $105 million represents roughly 1.8% of market cap at current levels, a conservative approach typical of beverage companies balancing capital returns with investment in growth and acquisitions.
Will this repurchase program affect the company's financial flexibility?: No material effect is expected. Vita Coco maintains a strong balance sheet with $279 million in cash and zero debt as of June 30, 2026. The company also raised full-year 2026 guidance, indicating confidence in cash flow generation sufficient to fund operations, growth investments (including the Copra acquisition), and the buyback program.
What is the timing and duration of the repurchase authorization?: The filing does not specify an expiration date for the authorization or details on timing of share repurchases. Repurchases typically occur opportunistically under Rule 10b-18 safe harbor or through a 10b5-1 trading plan unless otherwise specified by the board.

authorization mid-cap beverage-sector execution-not-specified strong-balance-sheet

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.